10x Genomics (TXG) Operating Margin Growth (3y) (2021 - 2026)
Powered by 
Analysis
10x Genomics (TXG) Operating Margin Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn | 263.00 |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn | -168.00 |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn | 1,569.00 |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn | 2,862.00 |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn | 123.00 |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn | -825.00 |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn | -201.00 |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn | -527.00 |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn | -2,043.00 |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn | 3,021.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,021.00 |
| Mar 31, 2026 | 2,741.00 |
| Dec 31, 2025 | 301.00 |
| Sep 30, 2025 | 888.00 |
| Jun 30, 2025 | 7,249.00 |
| Mar 31, 2025 | 1,106.00 |
| Dec 31, 2024 | -1,917.00 |
| Sep 30, 2024 | -1,468.00 |
| Jun 30, 2024 | -1,834.00 |
| Mar 31, 2024 | -3,396.00 |
| Dec 31, 2023 | 33,499.00 |
| Sep 30, 2023 | 2,917.00 |
| Jun 30, 2023 | 4,872.00 |
| Mar 31, 2023 | -1,106.00 |
| Dec 31, 2022 | -405.00 |
| Sep 30, 2022 | -1,565.00 |
| Jun 30, 2022 | -3,651.00 |
| Mar 31, 2022 | -3,079.00 |
| Dec 31, 2021 | 13,726.00 |
| Sep 30, 2021 | 2,812.00 |